Engrail Therapeutics

Developer of therapeutic compounds to treat neurological diseases

placeSan Diego, California, United States calendar_todayFounded 2019 groups16 employees language engrail.com

Registered entities

Social engagement

Social engagement: 4.7K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include F-Prime Capital, Forbion, Nan Fung Life Sciences.

Investor typeCountShare
Venture capital1091%
Other / undisclosed19%
Coming soon